COMPASS Pathways plc SEC filings CMPS

COMPASS Pathways plc has 344 filings in SEC EDGAR's recent list, going back to Jul 2, 2020. Its latest annual report, Form ARS, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations). The company's fiscal year ends on December 31.

COMPASS Pathways plc SEC filings
Form Description Filed Period
8-K Current report
Results of operations
Nov 3, 2026 Nov 3, 2026
10-Q Quarterly report Nov 3, 2026 Sep 30, 2026
S-3ASR Automatic shelf registration Aug 5, 2026 —
8-K Current report
Results of operations
Aug 5, 2026 Aug 5, 2026
10-Q Quarterly report Aug 5, 2026 Jun 30, 2026
8-K Current report
Regulation FD disclosure, Other events
Jul 7, 2026 Jul 7, 2026
8-K Current report
Shareholder vote results
May 28, 2026 May 27, 2026
8-K Current report
Results of operations
May 13, 2026 May 13, 2026
10-Q Quarterly report May 13, 2026 Mar 31, 2026
ARS Annual report to shareholders Apr 15, 2026 Dec 31, 2025
DEF 14A Proxy statement Apr 15, 2026 May 27, 2026
S-8 Employee stock plan registration Mar 24, 2026 —
S-8 Employee stock plan registration Mar 24, 2026 —
10-K Annual report Mar 24, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 24, 2026 Mar 24, 2026
8-K Current report
Material agreement, Regulation FD disclosure
Feb 19, 2026 Feb 18, 2026
424B5 Prospectus supplement Feb 19, 2026 —
424B5 Prospectus supplement Feb 17, 2026 —
8-K Current report
Regulation FD disclosure, Other events
Feb 17, 2026 Feb 17, 2026
8-K Current report
Material agreement, New debt
Jan 7, 2026 Jan 5, 2026
10-Q Quarterly report Nov 4, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 4, 2025 Nov 4, 2025
8-K Current report
Officer or director change
Oct 29, 2025 Oct 26, 2025
8-K Current report
Results of operations
Jul 31, 2025 Jul 31, 2025
10-Q Quarterly report Jul 31, 2025 Jun 30, 2025
8-K Current report
Officer or director change
Jul 29, 2025 Jul 28, 2025
8-K Current report
Other events
Jun 23, 2025 Jun 23, 2025
8-K Current report
Shareholder vote results
Jun 13, 2025 Jun 12, 2025
8-K Current report
Results of operations
May 8, 2025 May 8, 2025
10-Q Quarterly report May 8, 2025 Mar 31, 2025
424B5 Prospectus supplement May 8, 2025 —
EFFECT Filing May 7, 2025 —
CORRESP Letter to the SEC May 5, 2025 —
ARS Annual report to shareholders Apr 28, 2025 Dec 31, 2024
DEF 14A Proxy statement Apr 28, 2025 Apr 28, 2025
PRE 14A Preliminary proxy statement Apr 16, 2025 Apr 16, 2025
8-K Current report
Auditor change, Officer or director change
Apr 16, 2025 Apr 14, 2025
UPLOAD Letter from the SEC Mar 6, 2025 —
S-8 Employee stock plan registration Feb 27, 2025 —
S-3 Shelf registration Feb 27, 2025 —
8-K Current report
Results of operations
Feb 27, 2025 Feb 27, 2025
10-K Annual report Feb 27, 2025 Dec 31, 2024
424B5 Prospectus supplement Jan 10, 2025 —
8-K Current report
Material agreement, Regulation FD disclosure, Other events
Jan 10, 2025 Jan 9, 2025
8-K Current report
Results of operations
Oct 31, 2024 Oct 31, 2024
10-Q Quarterly report Oct 31, 2024 Sep 30, 2024
424B5 Prospectus supplement Oct 18, 2024 —
EFFECT Filing Oct 17, 2024 —
CORRESP Letter to the SEC Oct 15, 2024 —
UPLOAD Letter from the SEC Oct 11, 2024 —
S-3 Shelf registration Oct 7, 2024 —
8-K Current report
Results of operations, Officer or director change
Aug 1, 2024 Jul 30, 2024
10-Q Quarterly report Aug 1, 2024 Jun 30, 2024
F-6EF Filing May 15, 2024 —
8-K Current report
Shareholder vote results, Other events
May 9, 2024 May 9, 2024
8-K Current report
Results of operations
May 8, 2024 May 8, 2024
10-Q Quarterly report May 8, 2024 Mar 31, 2024
8-K Current report
Other events
May 8, 2024 May 8, 2024
ARS Annual report to shareholders Apr 8, 2024 Dec 31, 2023
DEF 14A Proxy statement Apr 8, 2024 Apr 8, 2024
PRE 14A Preliminary proxy statement Mar 28, 2024 Mar 28, 2024
8-K Current report
Officer or director change, Regulation FD disclosure
Mar 28, 2024 Mar 27, 2024
8-K Current report
Results of operations
Feb 29, 2024 Feb 29, 2024
10-K Annual report Feb 29, 2024 Dec 31, 2023
S-8 Employee stock plan registration Jan 5, 2024 —
8-K Current report
Officer or director change, Regulation FD disclosure
Dec 7, 2023 Dec 5, 2023
8-K Current report
Results of operations
Nov 2, 2023 Nov 2, 2023
10-Q Quarterly report Nov 2, 2023 Sep 30, 2023
8-K Current report
Officer or director change, Regulation FD disclosure
Oct 26, 2023 Oct 24, 2023
424B3 Prospectus Sep 19, 2023 —
EFFECT Filing Sep 18, 2023 —
8-K Current report
Officer or director change, Regulation FD disclosure
Sep 18, 2023 Sep 13, 2023
CORRESP Letter to the SEC Sep 14, 2023 —
UPLOAD Letter from the SEC Sep 14, 2023 —
S-3 Shelf registration Sep 8, 2023 —
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Aug 16, 2023 Aug 16, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Aug 3, 2023 Aug 3, 2023
10-Q Quarterly report Aug 3, 2023 Jun 30, 2023
8-K Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
Jul 5, 2023 Jun 30, 2023
8-K Current report
Shareholder vote results
Jun 5, 2023 Jun 2, 2023
8-K Current report
Officer or director change, Regulation FD disclosure
May 31, 2023 May 30, 2023
8-K Current report
Results of operations
May 11, 2023 May 11, 2023
10-Q Quarterly report May 11, 2023 Mar 31, 2023
ARS Annual report to shareholders Apr 19, 2023 Apr 19, 2023
DEF 14A Proxy statement Apr 19, 2023 Apr 19, 2023
8-K Current report
Regulation FD disclosure
Apr 19, 2023 Apr 19, 2023
8-K Current report
Results of operations
Feb 28, 2023 Feb 28, 2023
10-K Annual report Feb 28, 2023 Dec 31, 2022
S-8 Employee stock plan registration Jan 20, 2023 —
8-K Current report
Regulation FD disclosure
Jan 6, 2023 Jan 6, 2023
8-K Current report
Results of operations
Nov 3, 2022 Nov 3, 2022
10-Q Quarterly report Nov 3, 2022 Sep 30, 2022
S-8 Employee stock plan registration Aug 4, 2022 —
8-K Current report Aug 4, 2022 Aug 4, 2022
10-Q Quarterly report Aug 4, 2022 Jun 30, 2022
8-K Current report
Officer or director change, Regulation FD disclosure
Jul 19, 2022 Jul 19, 2022
S-8 Employee stock plan registration Jul 1, 2022 —
8-K Current report
Regulation FD disclosure
Jun 24, 2022 Jun 22, 2022
8-K Current report
Shareholder vote results
Jun 17, 2022 Jun 16, 2022
10-Q Quarterly report May 10, 2022 Mar 31, 2022
8-K Current report May 10, 2022 May 10, 2022
424B5 Prospectus supplement May 6, 2022 —
EFFECT Filing May 3, 2022 —
DEF 14A Proxy statement Apr 28, 2022 Jun 16, 2022
8-K Current report
Officer or director change
Apr 21, 2022 Apr 19, 2022
8-K Current report
Material agreement, Other events
Mar 25, 2022 Mar 24, 2022
8-K Current report
Results of operations
Feb 24, 2022 Feb 24, 2022
POS AM Filing Feb 24, 2022 —
10-K Annual report Feb 24, 2022 Dec 31, 2021
POSASR Filing Feb 24, 2022 —
8-K Current report
Officer or director change
Feb 4, 2022 Feb 1, 2022
6-K Current report (foreign issuer) Dec 22, 2021 Dec 16, 2021
6-K Current report (foreign issuer) Dec 7, 2021 Dec 3, 2021
6-K Current report (foreign issuer) Dec 2, 2021 Dec 1, 2021
6-K Current report (foreign issuer) Nov 23, 2021 Nov 23, 2021
6-K Current report (foreign issuer) Nov 9, 2021 Sep 30, 2021
6-K Current report (foreign issuer) Nov 9, 2021 Nov 9, 2021
6-K Current report (foreign issuer) Nov 4, 2021 Nov 3, 2021
6-K Current report (foreign issuer) Oct 21, 2021 Oct 20, 2021
6-K Current report (foreign issuer) Oct 19, 2021 Oct 19, 2021
F-3ASR F-3 Oct 8, 2021 —
6-K Current report (foreign issuer) Oct 1, 2021 Sep 30, 2021
6-K Current report (foreign issuer) Sep 15, 2021 Sep 15, 2021
6-K Current report (foreign issuer) Aug 11, 2021 Jun 30, 2021
6-K Current report (foreign issuer) Jul 30, 2021 Jul 29, 2021
6-K Current report (foreign issuer) Jun 24, 2021 Jun 24, 2021
6-K Current report (foreign issuer) May 24, 2021 May 24, 2021
6-K Current report (foreign issuer) May 17, 2021 May 14, 2021
6-K Current report (foreign issuer) May 13, 2021 Mar 31, 2021
424B4 Prospectus Apr 30, 2021 —
EFFECT Filing Apr 29, 2021 —
F-1MEF Filing Apr 29, 2021 —
F-1/A Filing Apr 28, 2021 —
CORRESP Letter to the SEC Apr 27, 2021 —
CORRESP Letter to the SEC Apr 27, 2021 —
F-1 Registration statement (foreign issuer) Apr 27, 2021 —
6-K Current report (foreign issuer) Apr 15, 2021 Apr 15, 2021
6-K Current report (foreign issuer) Apr 1, 2021 Apr 1, 2021
6-K Current report (foreign issuer) Mar 23, 2021 Mar 23, 2021
6-K Current report (foreign issuer) Mar 12, 2021 Mar 9, 2021
20-F Annual report (foreign issuer) Mar 9, 2021 Dec 31, 2020
UPLOAD Letter from the SEC Mar 8, 2021 —
DRS Filing Mar 4, 2021 —
6-K Current report (foreign issuer) Feb 9, 2021 Feb 9, 2021
6-K Current report (foreign issuer) Nov 12, 2020 Sep 30, 2020
S-8 Employee stock plan registration Oct 9, 2020 —
424B4 Prospectus Sep 21, 2020 —
EFFECT Filing Sep 17, 2020 —
EFFECT Filing Sep 17, 2020 —
F-1MEF Filing Sep 17, 2020 —
CERT 8a cert Sep 17, 2020 —
F-6/A Filing Sep 17, 2020 —
8-A12B Filing Sep 15, 2020 —
CORRESP Letter to the SEC Sep 15, 2020 —
CORRESP Letter to the SEC Sep 15, 2020 —
F-1/A Filing Sep 14, 2020 —
CORRESP Letter to the SEC Sep 9, 2020 —
UPLOAD Letter from the SEC Sep 8, 2020 —
CORRESP Letter to the SEC Sep 2, 2020 —
F-6 Filing Aug 31, 2020 —
F-1 Registration statement (foreign issuer) Aug 28, 2020 —
DRSLTR Filing Aug 10, 2020 —
DRS/A Filing Aug 10, 2020 —
UPLOAD Letter from the SEC Jul 31, 2020 —
DRS Filing Jul 2, 2020 —

Showing 165 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
CMPS (Nasdaq)
Fiscal year ends
December 31
Incorporated in
United Kingdom
Headquarters
Chesire, United Kingdom
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1816590
Former names
Compass Rx Ltd. (until Aug 10, 2020)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.